pharma
Tonix plunges 68% after PTSD drug failure
July 30, 2018Research and Development, Sales and Marketing PTSD, Tonmya, pharma, tonix
Tonix Pharmaceuticals has announced that it has terminated its Phase 3 study of Tonmya (cyclobenzaprine HCl sublingual tablets) in military-related …
Army to ferry medicines in case of no-deal Brexit
July 30, 2018Sales and Marketing UK, army, brexit, medicines, pharma, politics, supply chains
Ministers have established plans to use the army to deliver medicines, food and fuel in the event of a no-deal …
Top Ten most popular articles on Pharmafile.com this week
July 27, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, China, GSK, Gilead, J&J, JJ, Pfizer, Remicade, Roche, antimicrobial resistance, biosimilar, pharma, pricing, viagra
With the UK in the grip of a record-breaking heatwave, it’s hard to focus on much else over here, but …
Takeda’s Alunbrig topples Pfizer’s Xalkori in ALK-positive lung cancer
July 27, 2018Medical Communications, Research and Development Alunbrig, Cancer, NSCLC, Pfizer, Takeda, Xalkori, lung cancer, pharma
Takeda has unveiled new Phase 3 data showing that its tyrosine kinase inhibitor (TKI) Alunbrig (brigatinib) not only met its …
GSK forges $300m partnership with 23andMe to boost preclinical R&D
July 26, 2018Research and Development 23andME, GSK, GlaxoSmithKline, collaboration, genetics, pharma
In a bid to supercharge its drug discovery efforts, GlaxoSmithKline has sealed a $300 million deal with personal genomics and …
Gilead’s CEO and Chairman to both step down before year’s end
July 26, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, pharma
Gilead has announced that its President and Chief Executive Officer Dr John Milligan (pictured) will be stepping down by the …
NHS to stockpile drugs in preparation for no-deal Brexit
July 25, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, brexit, government, pharma, stockpiling
Secretary of State for Health and Social Care, Matt Hancock, has said that the NHS is preparing to stockpile medicines …
FDA approves first endometriosis pain management drug in a decade
July 25, 2018Research and Development, Sales and Marketing AbbVie, FDA, Neurocrine Biosciences, endometriosis, pharma
The FDA has confirmed its approval of AbbVie and Neurocrine Biosciences’ Orilissa (elagolix), a nonpeptide small molecule gonadotropin-releasing hormone (GnRH) …
Pfizer to build $465m sterile injectable plant in Michigan
July 25, 2018Manufacturing and Production, Research and Development Michigan, Pfizer, US, manufacturing, pharma
Pfizer has unveiled plans to invest $465 million to build a new sterile injectables plant in Portage, Michigan, saying that …
Celgene’s Revlimid combo meets Phase 3 goal in relapsed/refractory indolent lymphoma
July 24, 2018Manufacturing and Production, Research and Development Celgene, Revlimid, lymphoma, pharma
Celgene has lifted the curtain on new Phase 3 data for its combo of Revlimid (lenalidomide) plus rituximab (R2) in …
AstraZeneca jettisons European heart drug rights for $210m
July 24, 2018Manufacturing and Production, Sales and Marketing AstraZeneca, Atacand, Cheplapharm, blood pressure, heart failure, pharma
AstraZeneca has announced its intention to hand over the European commercial rights to its heart failure and blood pressure treatment …
The mission against antimicrobial resistance
July 23, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antibiotic resistance, antimicrobial resistance, feature, pharma
Two headlines have highlighted the ‘here and now’ of the threat of rising antimicrobial resistance (AMR), writes Dr Peter Jackson.A …
US court overturns Allergan’s controversial attempts to avoid Restasis patent review
July 23, 2018Sales and Marketing Allergan, Mylan, Restasis, US, dry eye, pharma
The US Court of Appeals for the Federal Circuit has seen fit to authorise a US Patent and Trademark Office …
FDA approves Pfizer biosimilar version of Amgen’s Neupogen
July 23, 2018Sales and Marketing Amgen, FDA, Neupogen, Nivestym, Pfizer, pharma
The FDA has announced its decision to approve Pfizer’s Nivestym, the firm’s biosimilar version of Amgen’s Neupogen (filgrastim), for use …
Janssen’s Symtuza scores approval with the FDA in HIV-1
July 18, 2018Sales and Marketing HIV, Janssen, Symtuza, pharma
Janssen has announced that Symtuza (D/C/F/TAF) has received approval from the FDA in the treatment of human immunodeficiency virus type …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
